{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-026802","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2022-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.502665+00:00","generated_at":"2026-06-23T07:28:10.250921+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Oncocyte appoints James Liu as Controller & Principal Accounting Officer","bullets":["James Liu, 27, appointed Controller & Principal Accounting Officer effective Sept 20, 2022.","Liu previously served as Interim Controller since July 2022 and as Manager of SEC Reporting & Compliance.","Annual salary of $175,000; eligible for discretionary annual bonus with target of 30% of base salary.","Receives one-time grant of 75,000 stock options vesting 25% after 1 year, then monthly over 3 years.","No family relationships or related party transactions with the company's directors or officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-026802","json":"https://secwatch.observer/filing/0001493152-22-026802.json","markdown":"https://secwatch.observer/filing/0001493152-22-026802.md","text":"https://secwatch.observer/filing/0001493152-22-026802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222026802/0001493152-22-026802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222026802/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T07:28:10.250921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0095d7cfb0","claim":"James Liu was appointed as Controller & Principal Accounting Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"Effective September 20, 2022, Oncocyte Corporation (“Oncocyte” or the “Company”) appointed James Liu as the Company’s Controller & Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222026802/0001493152-22-026802-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Controller & Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}